Hostname: page-component-848d4c4894-sjtt6 Total loading time: 0 Render date: 2024-06-20T13:26:53.506Z Has data issue: false hasContentIssue false

Low vitamin B12 and elevated folate status in older adults-a risk factor for cognitive impairment?

Published online by Cambridge University Press:  11 September 2015

E. Laird
Affiliation:
School of Medicine, Trinity College, Dublin 2Ireland
H. McNulty
Affiliation:
Northern Ireland Centre for Food and Health, University of Ulster, Coleraine, BT52 1SA, UK
M. Ward
Affiliation:
Northern Ireland Centre for Food and Health, University of Ulster, Coleraine, BT52 1SA, UK
L. Hoey
Affiliation:
Northern Ireland Centre for Food and Health, University of Ulster, Coleraine, BT52 1SA, UK
J.J. Strain
Affiliation:
Northern Ireland Centre for Food and Health, University of Ulster, Coleraine, BT52 1SA, UK
M. Casey
Affiliation:
The Mercers Institute for Research on Ageing, St James's Hospital, Dublin, Ireland
C. Cunningham
Affiliation:
The Mercers Institute for Research on Ageing, St James's Hospital, Dublin, Ireland
A.M. Molloy
Affiliation:
School of Medicine, Trinity College, Dublin 2Ireland
Rights & Permissions [Opens in a new window]

Abstract

Type
Abstract
Copyright
Copyright © The Authors 2015 

Studies post mandatory folic acid fortification in the US suggest that older adults with high folate but low vitamin B12 status have higher methylmalonic acid (MMA) and homocysteine (tHcy) concentrations as well as a higher risk of cognitive impairment compared to those with low B12 and normal folate status( Reference Miller, Garrod and Allen 1 Reference Reynolds 4 ). However, studies from countries with voluntary but not mandatory folic acid fortification do not support these findings( Reference Clarke, Sherliker and Hin 5 , Reference Mills, Carter and Scott 6 ). Therefore, the aim of this study was to investigate folate and B12 status in relation to cognitive function in a large well-characterised older adult population exposed to a voluntary but liberal food fortification policy.

Participants (n 5186) were from the Trinity Ulster Department of Agriculture (TUDA) Study, a large study of older Irish adults designed to investigate gene-nutrient interactions in the development of chronic diseases of ageing. Participants were recruited from General Practitioner practices in the Western and Northern Health and Social Care Trusts, Northern Ireland and those attending the memory and bone clinics in the Geriatric Unit of St. James Hospital, Dublin, Ireland. Blood samples were analysed for total serum cobalamin, holotranscobalamin, homocysteine (tHcy), red cell folate (RCF) folate and serum folate. Methylmalonic acid (MMA) determination was performed on a subset of samples (n 1477). Haematological and renal function data were accessed from the main study database. Cognitive function was assessed by repeatable battery for the assessment of neuropsychological status (RBANS) with a score ⩽80 indicating cognitive impairment. The population was divided into 4 categories based on serum B12 (<148 compared to ⩾148 pmol/L) and serum folate (< 60 and ⩾60 nmol/L) concentrations.

Participants with either low B12 and low folate or low B12 and high folate status had significantly higher MMA and tHcy concentrations compared to the other groups (P < 0·05). Those with low B12 and high folate status (n 54) were significantly older, had a higher frequency of anaemia and cognitive impairment and had a higher use of folic acid supplements than all other groups (P < 0·05). These observational findings suggest that the classification criterion of low B12/high folate artificially selects the oldest old who are the frailest, most cognitively impaired and the most heavily supplemented with folic acid.

Acknowledgement of Funding: The Irish Department of Agriculture, Food and the Marine (DAFF) and the Northern Ireland Department for Employment & Learning (DEL) through its “Strengthening the All-Island Research Base” initiative. Funding of MMA analysis: Axis Shield Diagnostics, Dundee, Scotland.

References

1. Miller, JW, Garrod, MG, Allen, LH et al. (2009) Am J Clin Nutr 90, 15861592.Google Scholar
2. Selhub, J, Morris, MS & Jacques, PF. (2007) Proc Natl Acad Sci USA 104, 1999520000.Google Scholar
3. Morris, MS, Jacques, PF, Rosenberg, IH et al. (2007) Am J Clin Nutr 85, 193200.Google Scholar
4. Reynolds, E. (2006) Lancet Neurol 5, 949960.Google Scholar
5. Clarke, R, Sherliker, P, Hin, H et al. (2008) BJN 100, 10541059.CrossRefGoogle Scholar
6. Mills, JL, Carter, TC, Scott, JM et al. (2011) Am J Clin Nutr 94, 495500.CrossRefGoogle Scholar